obesity glp-1 news today Injections of an ultra-long-acting investigational agonist led to significant weight loss in people with overweight or obesity, with reductions continuing after a switch to once-monthly dosing, according to the ongoing VESPER GLP-1 Prescriptions Quadruple Since 2021

ADHD is also treated with non-stimulant drugs such as atomoxetine (Strattera), guanfacine (Intuniv, Tenex), clonidine (Kayvay), and viloxazine ( Quelbree )

Most patients undergo a series of 1 to 3 treatments spaced 4 to 6 weeks apart, with results appearing gradually: 1 to 2 months: Reduced shedding and improved scalp health 3 to 4 months: Noticeable improvement in hair thickness and density 5 to 6 months: Continued growth and fuller appearance Exosome therapy at NuBody Concepts starts at $600 for a single treatment (1ml dose), with package pricing for a series of three treatments starting at $1,650

While it supports systemic recovery, it does not offer the same focused healing properties that BPC-157 does

Clinical trials examining cardiovascular outcomes in patients taking GLP-1 receptor agonists have not identified increased rates of serious infections compared with placebo groups

Lyophilized (powder) GHK-Cu remains stable refrigerated for extended periods

Diabetes Care 1 January 2023